Delaet Ingrid
Insider CIK 1965808 · NBIX Chief Regulatory Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-09-11 | 2026-09-15 | 2,419 | $156.22 | $377.9K | 18,289 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-09-11 | 2026-09-15 | 4,483 | — | $0 | 20,708 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-09-11 | 2026-09-15 | 2,419 | $156.22 | $377.9K | 18,289 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-09-11 | 2026-09-15 | 4,483 | — | $0 | 20,708 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-07-10 | 2026-07-13 | 4,367 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-07-10 | 2026-07-13 | 4,367 | $181.02 | $790.5K | 16,225 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-07-10 | 2026-07-13 | 4,367 | $106.02 | $463.0K | 20,592 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-07-09 | 2026-07-09 | 8,433 | — | $0 | 7,478 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-07-09 | 2026-07-09 | 8,433 | $178.72 | $1.51M | 16,225 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-07-09 | 2026-07-09 | 8,433 | $103.52 | $873.0K | 24,658 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-07-08 | 2026-07-09 | 2,737 | — | $0 | 15,911 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-07-08 | 2026-07-09 | 2,737 | $103.52 | $283.3K | 18,962 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-07-08 | 2026-07-09 | 2,737 | $178.54 | $488.7K | 16,225 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-07-07 | 2026-07-09 | 3,401 | — | $0 | 18,648 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-07-07 | 2026-07-09 | 3,401 | $178.57 | $607.3K | 16,225 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-07-07 | 2026-07-09 | 3,401 | $103.52 | $352.1K | 19,626 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-05-29 | 2026-06-02 | 2,261 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-05-29 | 2026-06-02 | 2,261 | $156.71 | $354.3K | 16,225 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-05-29 | 2026-06-02 | 2,261 | $79.02 | $178.7K | 18,486 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-13 | 2026-02-17 | 1,359 | — | $0 | 1,359 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-02-13 | 2026-02-17 | 5,479 | — | $0 | 5,479 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-02-13 | 2026-02-17 | 31,234 | — | $0 | 31,234 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-13 | 2026-02-17 | 1,401 | — | $0 | 2,802 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 734 | $124.12 | $91.1K | 7,045 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-13 | 2026-02-17 | 1,359 | — | $0 | 7,779 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award | 2026-02-13 | 2026-02-17 | 19,935 | — | $0 | 26,980 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 10,755 | $124.12 | $1.33M | 16,225 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-13 | 2026-02-17 | 1,401 | — | $0 | 7,176 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-13 | 2026-02-17 | 756 | $124.12 | $93.8K | 6,420 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-02-12 | 2026-02-17 | 1,600 | — | $0 | 4,801 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-02-12 | 2026-02-17 | 1,600 | — | $0 | 6,656 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-02-12 | 2026-02-17 | 881 | $123.10 | $108.5K | 5,775 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-01-31 | 2026-02-03 | 801 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-01-31 | 2026-02-03 | 801 | — | $0 | 5,531 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2026-01-31 | 2026-02-03 | 475 | $136.06 | $64.6K | 5,056 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-07-10 | 2025-07-11 | 457 | — | $0 | 2,261 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-07-10 | 2025-07-11 | 457 | $135.00 | $61.7K | 4,730 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-07-10 | 2025-07-11 | 457 | $79.02 | $36.1K | 5,187 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 1,358 | — | $0 | 2,718 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-13 | 2025-02-14 | 1,401 | — | $0 | 4,203 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 716 | $116.69 | $83.6K | 4,084 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-13 | 2025-02-14 | 755 | $116.72 | $88.1K | 4,730 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 1,401 | — | $0 | 5,485 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-13 | 2025-02-14 | 1,358 | — | $0 | 4,800 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-02-12 | 2025-02-14 | 6,401 | — | $0 | 6,401 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-02-12 | 2025-02-14 | 34,153 | — | $0 | 34,153 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-02-03 | 2025-02-04 | 1,179 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-02-03 | 2025-02-04 | 1,179 | — | $0 | 4,065 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-02-03 | 2025-02-04 | 623 | $149.29 | $93.0K | 3,442 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-01-31 | 2025-02-04 | 801 | — | $0 | 801 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-01-31 | 2025-02-04 | 801 | — | $0 | 3,308 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2025-01-31 | 2025-02-04 | 422 | $153.05 | $64.6K | 2,886 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-12-31 | 2025-01-03 | 272 | — | $0 | 2,718 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-12-31 | 2025-01-03 | 272 | $138.10 | $37.6K | 2,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-12-31 | 2025-01-03 | 272 | $79.02 | $21.5K | 2,779 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-12-17 | 2024-12-19 | 1,091 | — | $0 | 2,990 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-12-17 | 2024-12-19 | 1,091 | $135.00 | $147.3K | 2,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-12-17 | 2024-12-19 | 1,091 | $79.02 | $86.2K | 3,598 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-08-13 | 2024-08-15 | 3,043 | — | $0 | 22,049 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-08-13 | 2024-08-15 | 3,043 | $150.13 | $456.8K | 6,607 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-08-13 | 2024-08-15 | 4,100 | $150.08 | $615.3K | 2,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-08-13 | 2024-08-15 | 3,043 | $103.52 | $315.0K | 9,650 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-08-06 | 2024-08-08 | 273 | — | $0 | 4,081 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-08-06 | 2024-08-08 | 273 | $147.70 | $40.3K | 6,607 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-08-06 | 2024-08-08 | 273 | $79.02 | $21.6K | 6,880 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-07-16 | 2024-07-18 | 400 | — | $0 | 26,649 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-07-16 | 2024-07-18 | 1,557 | — | $0 | 25,092 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-07-16 | 2024-07-18 | 1,557 | $103.52 | $161.2K | 9,064 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-07-16 | 2024-07-18 | 1,557 | $150.00 | $233.6K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-07-16 | 2024-07-18 | 900 | $150.04 | $135.0K | 6,607 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-07-16 | 2024-07-18 | 400 | $150.10 | $60.0K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-07-16 | 2024-07-18 | 400 | $103.52 | $41.4K | 7,907 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-07-01 | 2024-07-02 | 272 | — | $0 | 4,354 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-07-01 | 2024-07-02 | 272 | $138.11 | $37.6K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-07-01 | 2024-07-02 | 272 | $79.02 | $21.5K | 7,779 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-05-31 | 2024-06-04 | 273 | — | $0 | 4,626 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-05-31 | 2024-06-04 | 273 | $136.55 | $37.3K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-05-31 | 2024-06-04 | 273 | $79.02 | $21.6K | 7,780 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-05-06 | 2024-05-08 | 273 | $79.02 | $21.6K | 4,899 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-05-06 | 2024-05-08 | 273 | $140.55 | $38.4K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-05-06 | 2024-05-08 | 273 | $79.02 | $21.6K | 7,780 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-04-01 | 2024-04-03 | 272 | $79.02 | $21.5K | 5,172 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-04-01 | 2024-04-03 | 272 | $79.02 | $21.5K | 7,779 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-04-01 | 2024-04-03 | 272 | $137.30 | $37.3K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-03-21 | 2024-03-25 | 5,000 | $103.52 | $517.6K | 27,049 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-03-21 | 2024-03-25 | 5,000 | $103.52 | $517.6K | 12,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-03-21 | 2024-03-25 | 5,000 | $145.06 | $725.3K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-03-13 | 2024-03-15 | 3,000 | $106.02 | $318.1K | 4,367 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-03-13 | 2024-03-15 | 3,000 | $106.02 | $318.1K | 10,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-03-13 | 2024-03-15 | 3,000 | $140.14 | $420.4K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-03-11 | 2024-03-12 | 200 | $106.02 | $21.2K | 7,367 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-03-11 | 2024-03-12 | 200 | $106.02 | $21.2K | 7,707 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-03-11 | 2024-03-12 | 200 | $140.00 | $28.0K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-03-08 | 2024-03-12 | 1,800 | $106.02 | $190.8K | 7,567 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-03-08 | 2024-03-12 | 1,800 | $140.03 | $252.1K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-03-08 | 2024-03-12 | 1,800 | $106.02 | $190.8K | 9,307 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-02-29 | 2024-02-29 | 273 | $79.02 | $21.6K | 5,444 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-29 | 2024-02-29 | 273 | $135.51 | $37.0K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-02-29 | 2024-02-29 | 273 | $79.02 | $21.6K | 7,780 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-02-28 | 2024-02-29 | 1,544 | $79.02 | $122.0K | 5,717 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-02-28 | 2024-02-29 | 2,500 | $79.02 | $197.6K | 9,761 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-02-28 | 2024-02-29 | 2,500 | $79.02 | $197.6K | 7,261 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-28 | 2024-02-29 | 2,500 | $135.64 | $339.1K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-02-28 | 2024-02-29 | 2,500 | $79.02 | $197.6K | 10,007 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-02-28 | 2024-02-29 | 2,500 | $79.02 | $197.6K | 10,007 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-28 | 2024-02-29 | 2,500 | $134.62 | $336.6K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-02-28 | 2024-02-29 | 1,544 | $79.02 | $122.0K | 9,051 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-28 | 2024-02-29 | 1,544 | $136.00 | $210.0K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-02-13 | 2024-02-15 | 28,161 | — | $0 | 28,161 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-02-13 | 2024-02-15 | 5,604 | — | $0 | 5,604 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-13 | 2024-02-15 | 716 | $133.03 | $95.2K | 7,507 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-01 | 2024-02-02 | 623 | $139.77 | $87.1K | 6,865 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-01-31 | 2024-02-02 | 422 | $141.94 | $59.9K | 6,309 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-08-28 | 2023-08-30 | 1,431 | $107.52 | $153.9K | 5,931 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-08-21 | 2023-08-23 | 1,404 | $107.42 | $150.8K | 4,645 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-02-13 | 2023-02-15 | 33,771 | — | $0 | 33,771 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-02-13 | 2023-02-15 | 5,434 | — | $0 | 5,434 | SEC↗ |